New diabetes clinical trial: A Double-blinded, Randomized, Parallel, Placebo-controlled Trial of Wharton's Jelly-derived Allogeneic Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents

Published on: September 29, 2021 at 09:30PM
Condition:   Type1diabetes
Intervention:   Biological: the ATMP Protrans
Sponsor:   Uppsala University Hospital
Not yet recruiting
https://ift.tt/3kQuxkm